NIH-funded research NIH-funded research

Investigating how DNA in cells causes inflammation and aging

Official title: Role of cytosolic DNA-induced sterile inflammation driving cellular and organismal progeria/aging hallmarks

Funded at Saint Louis University · NIH-10901042 · Data updated 2026-11-12

This study is looking at how certain DNA in our cells can cause inflammation that speeds up aging and related diseases, especially in kids with Hutchinson-Gilford Progeria Syndrome, to find new ways to help improve their health.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionSaint Louis University
NIH-funded
Lab location1 site (Saint Louis, United States)
Project startSeptember 20, 2023
Project endAugust 31, 2025
Funding year2023
Award (this year)$378,750
NIH project number1R56AG082759-01
Project IDNIH-10901042 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals diagnosed with Hutchinson-Gilford Progeria Syndrome or those experiencing accelerated aging symptoms.

Less likely to help

Patients with typical aging processes or those without genetic predispositions to accelerated aging may not benefit from this research.

What this research studies

This research explores the role of cytosolic DNA in triggering inflammation that contributes to aging and related diseases, particularly focusing on Hutchinson-Gilford Progeria Syndrome (HGPS). The study aims to understand the mechanisms behind the accumulation of cytosolic DNA and its effects on cellular health and tissue deterioration. By examining the roles of specific proteins involved in inflammation, the researchers hope to identify potential therapeutic targets that could improve health outcomes for individuals with progeria and possibly other aging-related conditions. The approach includes both laboratory experiments and animal models to validate findings.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that improve health and longevity in patients with progeria and potentially other age-related diseases.

How similar studies have gone: Previous research has shown promising results in targeting inflammation pathways to improve healthspan and lifespan in animal models, suggesting potential for success in this approach.

Where this research is happening

  • Saint Louis University
    Saint Louis, United States
    Active

Researchers

  • Principal investigator: Gonzalo Hervas, Susana — Saint Louis University
  • Study coordinator: Gonzalo Hervas, Susana

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.